Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $552,897 - $671,784
7,735 Added 134.69%
13,478 $1.12 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $426,590 - $532,318
5,743 New
5,743 $443,000
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $214,729 - $273,861
-2,994 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $223,861 - $255,897
2,994 New
2,994 $231,000
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $462,045 - $518,830
-6,119 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $457,272 - $554,932
6,119 New
6,119 $462,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.